Evidence Synthesis
GENPHARMA's Gross Margin accelerated to 7.54%, up from 0.57%.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 5 Sept 2026, 03:57
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
GENPHARMA's Gross Margin accelerated to 7.54%, up from 0.57%.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 7.54 % | 0.57 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 0.57 % | 0.37 | ▲ |
| REVENUE_GROWTH_YOY | 312.8 % | — | - |
| PRICE_CHANGE_PERCENT | 0.806 % | — | - |
| DAILY_VOLUME | 11,91,433 shares | 6,22,227 | ▲ |
| CLOSE_PRICE | 1.25 INR | 1.24 | ▲ |